CIBC Private Wealth Group, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$2,941,000
-18.4%
29,496
+1.1%
0.01%
-30.0%
Q4 2020$3,605,000
+155.1%
29,163
+101.1%
0.01%
+150.0%
Q3 2020$1,413,000
+447.7%
14,499
+15.2%
0.00%
+300.0%
Q1 2018$258,000
-27.7%
12,5910.0%0.00%
-50.0%
Q4 2017$357,000
-8.9%
12,5910.0%0.00%0.0%
Q3 2017$392,000
-1.5%
12,5910.0%0.00%0.0%
Q2 2017$398,000
+39.6%
12,5910.0%0.00%0.0%
Q1 2017$285,00012,5910.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders